JPS608221A - 水虫薬 - Google Patents
水虫薬Info
- Publication number
- JPS608221A JPS608221A JP11647083A JP11647083A JPS608221A JP S608221 A JPS608221 A JP S608221A JP 11647083 A JP11647083 A JP 11647083A JP 11647083 A JP11647083 A JP 11647083A JP S608221 A JPS608221 A JP S608221A
- Authority
- JP
- Japan
- Prior art keywords
- foot
- athlete
- trichophyton
- aromatic halide
- main component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 title abstract description 11
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 claims abstract description 19
- 201000004647 tinea pedis Diseases 0.000 claims abstract description 19
- -1 aromatic halide Chemical class 0.000 claims abstract description 9
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 125000005843 halogen group Chemical group 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 abstract description 6
- 230000003902 lesion Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 2
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 241000223238 Trichophyton Species 0.000 abstract 5
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 210000003371 toe Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 2
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 2
- 229960002867 griseofulvin Drugs 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 241000257465 Echinoidea Species 0.000 description 1
- 235000015210 Fockea angustifolia Nutrition 0.000 description 1
- 244000186654 Fockea angustifolia Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000282798 Rhinocerotidae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11647083A JPS608221A (ja) | 1983-06-28 | 1983-06-28 | 水虫薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11647083A JPS608221A (ja) | 1983-06-28 | 1983-06-28 | 水虫薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS608221A true JPS608221A (ja) | 1985-01-17 |
| JPH0211566B2 JPH0211566B2 (https=) | 1990-03-14 |
Family
ID=14687897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11647083A Granted JPS608221A (ja) | 1983-06-28 | 1983-06-28 | 水虫薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS608221A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4162577B2 (ja) * | 2003-11-25 | 2008-10-08 | 株式会社東芝 | 加熱調理器およびその加熱調理器に用いられる調理器具 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5115637A (en) * | 1974-07-26 | 1976-02-07 | Yukio Kobayashi | Ch3 cooh to pentakurorufuenoorunokongonyoru satsukinseibutsushitsu |
-
1983
- 1983-06-28 JP JP11647083A patent/JPS608221A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5115637A (en) * | 1974-07-26 | 1976-02-07 | Yukio Kobayashi | Ch3 cooh to pentakurorufuenoorunokongonyoru satsukinseibutsushitsu |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0211566B2 (https=) | 1990-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LESSER | Testosterone propionate therapy in one hundred cases of angina pectoris | |
| Lewis et al. | Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone treatment | |
| US3795739A (en) | Treatment of parkinson disease | |
| Boland | Prednisone and prednisolone therapy in rheumatoid arthritis: Clinical evaluation based on continuous observations for periods of six to nine months | |
| US4210670A (en) | Antithrombotic agents | |
| Wechsler | Recovery in amyotrophic lateral sclerosis: treated with tocopherols (vitamin E): preliminary report | |
| Buckle | Treatment of thyroid crisis by beta-adrenergic blockade | |
| US2761807A (en) | Glycocyamine and methylating agent in vivo creatine producing composition | |
| Lionel et al. | Levamisole in the treatment of ascariasis in children | |
| Mckinney Jr et al. | Depression with the use of alpha-methyldopa | |
| JPS5938203B2 (ja) | 補酵素ｑを主成分とする脳循環障害治療剤 | |
| US5331012A (en) | Topical pharmaceutical preparation for fever blisters and other viral infections and method of use | |
| JPS608221A (ja) | 水虫薬 | |
| Silver et al. | Chronic arsenic poisoning following use of an asthma remedy | |
| US3039927A (en) | Pharmaceutical composition comprising aspirin and sorbitol | |
| WO1999016432A1 (en) | A drug for treating diabetic nephrosis | |
| US4006249A (en) | Systemic treatment of psoriasis | |
| US4073897A (en) | Treatment of arthritis and allied conditions with xenylsalate | |
| CN103189041B (zh) | 手指甲或脚趾甲生长促进用组合物 | |
| JP2002522507A (ja) | 疾患状態の処置 | |
| US3090724A (en) | Method of treating dermatological conditions | |
| JPS58213719A (ja) | 薬物的活性剤 | |
| EP1156830A2 (de) | Öl-in-wasser-emulsion zur verwendung als arzneimittel bzw. zur herstellung eines arzneimittels | |
| JPS62123132A (ja) | 気管支喘息治療用組成物 | |
| Law | The treatment of megacolon with parasympathetic drugs |